Assessing the Efficacy of Novel RYR2 Inhibitor, EL20, in Induced Pluripotent Stem Cell Derived Cardiomyocytes from a Catecholaminergic Polymorphic Ventricular Tachycardia Patient
Publication
, Conference
Word, TA; Landstrom, A; Quick, A; Shak, M; Miyake, C; Allen, HD; Wehrens, X
Published in: CIRCULATION RESEARCH
August 2, 2019
Duke Scholars
Published In
CIRCULATION RESEARCH
EISSN
1524-4571
ISSN
0009-7330
Publication Date
August 2, 2019
Volume
125
Location
Boston, MA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
14th Annual American-Heart-Association's Basic Cardiovascular Sciences (BCVS) Scientific Sessions - Integrative Approaches to Complex Cardiovascular Diseases
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Word, T. A., Landstrom, A., Quick, A., Shak, M., Miyake, C., Allen, H. D., & Wehrens, X. (2019). Assessing the Efficacy of Novel RYR2 Inhibitor, EL20, in Induced Pluripotent Stem Cell Derived Cardiomyocytes from a Catecholaminergic Polymorphic Ventricular Tachycardia Patient. In CIRCULATION RESEARCH (Vol. 125). Boston, MA: LIPPINCOTT WILLIAMS & WILKINS.
Word, Tarah A., Andrew Landstrom, Ann Quick, Mayra Shak, Christina Miyake, Hugh D. Allen, and Xander Wehrens. “Assessing the Efficacy of Novel RYR2 Inhibitor, EL20, in Induced Pluripotent Stem Cell Derived Cardiomyocytes from a Catecholaminergic Polymorphic Ventricular Tachycardia Patient.” In CIRCULATION RESEARCH, Vol. 125. LIPPINCOTT WILLIAMS & WILKINS, 2019.
Word TA, Landstrom A, Quick A, Shak M, Miyake C, Allen HD, et al. Assessing the Efficacy of Novel RYR2 Inhibitor, EL20, in Induced Pluripotent Stem Cell Derived Cardiomyocytes from a Catecholaminergic Polymorphic Ventricular Tachycardia Patient. In: CIRCULATION RESEARCH. LIPPINCOTT WILLIAMS & WILKINS; 2019.
Word, Tarah A., et al. “Assessing the Efficacy of Novel RYR2 Inhibitor, EL20, in Induced Pluripotent Stem Cell Derived Cardiomyocytes from a Catecholaminergic Polymorphic Ventricular Tachycardia Patient.” CIRCULATION RESEARCH, vol. 125, LIPPINCOTT WILLIAMS & WILKINS, 2019.
Word TA, Landstrom A, Quick A, Shak M, Miyake C, Allen HD, Wehrens X. Assessing the Efficacy of Novel RYR2 Inhibitor, EL20, in Induced Pluripotent Stem Cell Derived Cardiomyocytes from a Catecholaminergic Polymorphic Ventricular Tachycardia Patient. CIRCULATION RESEARCH. LIPPINCOTT WILLIAMS & WILKINS; 2019.
Published In
CIRCULATION RESEARCH
EISSN
1524-4571
ISSN
0009-7330
Publication Date
August 2, 2019
Volume
125
Location
Boston, MA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
14th Annual American-Heart-Association's Basic Cardiovascular Sciences (BCVS) Scientific Sessions - Integrative Approaches to Complex Cardiovascular Diseases
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology